🔗 Share this article Social Media Content Creators Fueling Parallel Market for Unlicensed Slimming Drug A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings. Experimental Drug Gaining Popularity Via Social Media Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also receiving discount codes. Active Commerce on Messaging Platforms Additionally, a robust market exists on Telegram, where groups with thousands of members share comparison photos, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for transactions. Learning About The Experimental Drug Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic. Medical Experts Express Worries Nevertheless, physicians and chemists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could result in individuals injecting products of unknown origin. Some experts said the demand for retatrutide could be connected to the increasing price of approved slimming treatments such as Mounjaro. Legal Status and Implementation Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012. Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment. Service Reaction and Material Elimination Based on the social media company, the service has removed problematic content and prohibited related keywords and query recommendations. The company stated it was committed to keeping the platform secure and allocating resources in enhancing compliance measures. Online Marketplace Operations Research also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, populated with photos of weight loss, positive testimonials and step-by-step guides for preparing or injecting at home. Within minutes of joining one community, a vendor shared contact information, where most purchases take place. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, health issues or previous experience. Item Information and Pricing Within these groups, posts display dark colored packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”. Service Oversight and Safety Measures A spokesperson for the messaging service said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Medical Professional Cautions “Individuals are injecting materials they can’t verify. Although the science behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service. A medical professional of an online medical service connected the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained. Her team has already encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or improperly measured.” Manufacturer Position A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose users to potentially significant health risks”.